Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma	Children's Hospital Los Angeles / Shahab Asgharzadeh, MD	Innovation Grants	2015	California
Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma	Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD	Innovation Grants	2015	Massachusetts
Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas	University of California, Davis Medical Center / Paul Knoepfler, PhD	Innovation Grants	2015	California
Synergistic Differentiation Therapy in Neuroblastoma	Duke University / Gerard Blobe, M.D./Ph.D	Innovation Grants	2015	North Carolina
In Vivo Analysis of Early Neuroblastoma Development using Transgenic Quail	Stowers Institute for Medical Research / Paul Kulesa, PhD	Innovation Grants	2015	Missouri
Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia	Boston Children's Hospital / Alan Cantor, MD, PhD	Innovation Grants	2015	Massachusetts
Single Cell Analysis of Leukemia Initiation	Stanford University / Michael Cleary, MD	Innovation Grants	2015	California
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma	Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP)	Innovation Grants	2015	Virginia
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy	University of North Carolina / Timothy Gershon, MD, PhD	Innovation Grants	2015	North Carolina
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma	Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD	Innovation Grants	2015	California

Pages